Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-01

Clinical Trial Update: Thiazolidinediones (TZD) Bone Loss and the Effects on Bone Marrow Differentiation and Osteoblast Formation

View source ↗

Summary

This completed clinical trial update investigates how thiazolidinediones affect bone loss, bone marrow differentiation, and osteoblast formation. The findings r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIOGLITAZONE (Pioglitazone)
  • Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Emory University | Conditions: Osteoporosis | Status: COMPLETED